• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在早发性阿尔茨海默病所致的轻度认知障碍中,脑炎症与tau蛋白高度共定位。

Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.

作者信息

Appleton Johanna, Finn Quentin, Zanotti-Fregonara Paolo, Yu Meixiang, Faridar Alireza, Nakawah Mohammad O, Zarate Carlos, Carrillo Maria C, Dickerson Bradford C, Rabinovici Gil D, Apostolova Liana G, Masdeu Joseph C, Pascual Belen

机构信息

Nantz National Alzheimer Center, Stanley H. Appel Department of Neurology, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, TX 77030, USA.

Molecular Imaging Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.

出版信息

Brain. 2025 Jan 7;148(1):119-132. doi: 10.1093/brain/awae234.

DOI:10.1093/brain/awae234
PMID:39013020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706285/
Abstract

Brain inflammation, with an increased density of microglia and macrophages, is an important component of Alzheimer's disease and a potential therapeutic target. However, it is incompletely characterized, particularly in patients whose disease begins before the age of 65 years and, thus, have few co-pathologies. Inflammation has been usefully imaged with translocator protein (TSPO) PET, but most inflammation PET tracers cannot image subjects with a low-binder TSPO rs6971 genotype. In an important development, participants with any TSPO genotype can be imaged with a novel tracer, 11C-ER176, that has a high binding potential and a more favourable metabolite profile than other TSPO tracers currently available. We applied 11C-ER176 to detect brain inflammation in mild cognitive impairment (MCI) caused by early-onset Alzheimer's disease. Furthermore, we sought to correlate the brain localization of inflammation, volume loss, elevated amyloid-β (Aβ)and tau. We studied brain inflammation in 25 patients with early-onset amnestic MCI (average age 59 ± 4.5 years, 10 female) and 23 healthy controls (average age 65 ± 6.0 years, 12 female), both groups with a similar proportion of all three TSPO-binding affinities. 11C-ER176 total distribution volume (VT), obtained with an arterial input function, was compared across patients and controls using voxel-wise and region-wise analyses. In addition to inflammation PET, most MCI patients had Aβ (n = 23) and tau PET (n = 21). For Aβ and tau tracers, standard uptake value ratios were calculated using cerebellar grey matter as region of reference. Regional correlations among the three tracers were determined. Data were corrected for partial volume effect. Cognitive performance was studied with standard neuropsychological tools. In MCI caused by early-onset Alzheimer's disease, there was inflammation in the default network, reaching statistical significance in precuneus and lateral temporal and parietal association cortex bilaterally, and in the right amygdala. Topographically, inflammation co-localized most strongly with tau (r = 0.63 ± 0.24). This correlation was higher than the co-localization of Aβ with tau (r = 0.55 ± 0.25) and of inflammation with Aβ (0.43 ± 0.22). Inflammation co-localized least with atrophy (-0.29 ± 0.26). These regional correlations could be detected in participants with any of the three rs6971 TSPO polymorphisms. Inflammation in Alzheimer's disease-related regions correlated with impaired cognitive scores. Our data highlight the importance of inflammation, a potential therapeutic target, in the Alzheimer's disease process. Furthermore, they support the notion that, as shown in experimental tissue and animal models, the propagation of tau in humans is associated with brain inflammation.

摘要

脑炎症,伴有小胶质细胞和巨噬细胞密度增加,是阿尔茨海默病的重要组成部分,也是一个潜在的治疗靶点。然而,其特征尚未完全明确,尤其是在65岁之前发病且合并症较少的患者中。炎症已通过转运蛋白(TSPO)PET进行有效成像,但大多数炎症PET示踪剂无法对TSPO rs6971基因型结合力低的受试者进行成像。一项重要进展是,任何TSPO基因型的参与者都可以使用新型示踪剂11C-ER176进行成像,该示踪剂具有高结合潜力,且代谢物谱比目前可用的其他TSPO示踪剂更有利。我们应用11C-ER176来检测早发型阿尔茨海默病所致轻度认知障碍(MCI)中的脑炎症。此外,我们试图将炎症的脑定位、体积损失、淀粉样β蛋白(Aβ)升高和tau蛋白进行关联。我们研究了25例早发型遗忘型MCI患者(平均年龄59±4.5岁,10名女性)和23名健康对照者(平均年龄65±6.0岁,12名女性)的脑炎症,两组中三种TSPO结合亲和力的比例相似。使用动脉输入函数获得的11C-ER176总分布容积(VT),通过体素分析和区域分析在患者和对照者之间进行比较。除了炎症PET外,大多数MCI患者还进行了Aβ(n = 2)和tau PET(n = 21)检查。对于Aβ和tau示踪剂,以小脑灰质作为参考区域计算标准摄取值比率。确定了三种示踪剂之间的区域相关性。对数据进行了部分容积效应校正。使用标准神经心理学工具研究认知表现。在早发型阿尔茨海默病所致的MCI中,默认网络存在炎症,在双侧楔前叶、颞叶外侧和顶叶联合皮质以及右侧杏仁核中达到统计学意义。在地形学上,炎症与tau蛋白的共定位最为强烈(r = 0.63±0.24)。这种相关性高于Aβ与tau蛋白的共定位(r = 0.55±0.25)以及炎症与Aβ的共定位(0.43±0.22)。炎症与萎缩的共定位最少(-0.29±0.26)。在具有三种rs6971 TSPO多态性中任何一种的参与者中都可以检测到这些区域相关性。阿尔茨海默病相关区域的炎症与认知评分受损相关。我们的数据突出了炎症这一潜在治疗靶点在阿尔茨海默病进程中的重要性。此外,它们支持了这样一种观点,即如在实验组织和动物模型中所示,tau蛋白在人类中的传播与脑炎症有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/402b3cc42deb/awae234f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/4409ad1a149f/awae234f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/a07380d649b2/awae234f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/e3544e4e8c77/awae234f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/65f09de8428b/awae234f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/402b3cc42deb/awae234f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/4409ad1a149f/awae234f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/a07380d649b2/awae234f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/e3544e4e8c77/awae234f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/65f09de8428b/awae234f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ab/11706285/402b3cc42deb/awae234f5.jpg

相似文献

1
Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.在早发性阿尔茨海默病所致的轻度认知障碍中,脑炎症与tau蛋白高度共定位。
Brain. 2025 Jan 7;148(1):119-132. doi: 10.1093/brain/awae234.
2
[C]ER176 images brain inflammation across TSPO genotypes and colocalizes with tau.[C]ER176可对不同TSPO基因型的脑部炎症进行成像,并与tau蛋白共定位。
Trends Neurosci. 2025 May;48(5):315-316. doi: 10.1016/j.tins.2025.03.005. Epub 2025 Apr 4.
3
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.TREM2 p.R47H 携带者和轻度认知障碍患者的小胶质细胞激活、tau 和淀粉样蛋白沉积:流感疫苗免疫挑战的多模态/多示踪剂 PET/MRI 成像研究。
J Neuroinflammation. 2023 Nov 21;20(1):272. doi: 10.1186/s12974-023-02945-0.
4
In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.在体放射性配体结合与阿尔茨海默病的严重程度相关。
Brain. 2013 Jul;136(Pt 7):2228-38. doi: 10.1093/brain/awt145. Epub 2013 Jun 17.
5
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.小胶质细胞活化与阿尔茨海默病中的 tau 和淀粉样蛋白在体内相关。
Brain. 2018 Sep 1;141(9):2740-2754. doi: 10.1093/brain/awy188.
6
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
7
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.描述阿尔茨海默病中淀粉样蛋白时间线上的脑 tau 与认知衰退。
Brain. 2024 Jun 3;147(6):2144-2157. doi: 10.1093/brain/awae116.
8
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.tau蛋白病变和神经退行性变导致阿尔茨海默病的认知障碍。
Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.
9
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
10
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.

引用本文的文献

1
Recent advances in neuroimaging of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症神经影像学的最新进展。
Alzheimers Dement. 2025 Sep;21(9):e70648. doi: 10.1002/alz.70648.
2
Anti-Neuroinflammation Effect of Standardized Ethanol Extract of Leaves of var. on Aβ-Induced Alzheimer's Disease-like Mouse Model.变种叶标准化乙醇提取物对Aβ诱导的阿尔茨海默病样小鼠模型的抗神经炎症作用
Pharmaceutics. 2025 Aug 12;17(8):1045. doi: 10.3390/pharmaceutics17081045.
3
Distinct inflammatory profiles in young-onset versus late-onset Alzheimer's disease.

本文引用的文献

1
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.阿尔茨海默病的临床病理异质性和神经胶质激活模式。
JAMA Neurol. 2024 Jun 1;81(6):619-629. doi: 10.1001/jamaneurol.2024.0784.
2
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.散发性早发性阿尔茨海默病的萎缩特征:来自纵向早发性阿尔茨海默病研究(LEADS)队列的初步发现。
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S74-S88. doi: 10.1002/alz.13466. Epub 2023 Oct 18.
3
Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.
早发型与晚发型阿尔茨海默病的不同炎症特征。
Alzheimers Dement. 2025 Jul;21(7):e70509. doi: 10.1002/alz.70509.
4
Amyloid-β plaque-associated microglia drive TSPO upregulation in Alzheimer's disease.淀粉样β蛋白斑块相关的小胶质细胞驱动阿尔茨海默病中转运体蛋白18 kDa(TSPO)的上调。
Acta Neuropathol. 2025 Jul 17;150(1):6. doi: 10.1007/s00401-025-02912-4.
5
Distinct 11C-ER176 PET Neuroinflammatory Profiles and Tau Colocalization in Progressive Apraxia of Speech With and Without Parkinson-plus Syndrome.伴有和不伴有帕金森叠加综合征的进行性言语失用症中独特的11C-ER176 PET神经炎症特征及tau蛋白共定位
Clin Nucl Med. 2025 Aug 1;50(8):731-742. doi: 10.1097/RLU.0000000000005962. Epub 2025 Jul 2.
6
Signs of Alzheimer's Disease: Tied to Aging.阿尔茨海默病的迹象:与衰老相关。
Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.
7
Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers.使用tau正电子发射断层扫描(PET)和血浆生物标志物预测阿尔茨海默病患者的纵向突触损失
Alzheimers Dement. 2025 May;21(5):e70333. doi: 10.1002/alz.70333.
8
Microglia-driven inflammation induces progressive tauopathies and synucleinopathies.小胶质细胞驱动的炎症会诱发进行性tau蛋白病和α-突触核蛋白病。
Exp Mol Med. 2025 May 1. doi: 10.1038/s12276-025-01450-z.
9
Anti-inflammatory effects of Zn-aspartate is accompanied by cognitive improvements in rats with Aβ-induced alzheimer disease.天门冬氨酸锌的抗炎作用伴随着β-淀粉样蛋白诱导的阿尔茨海默病大鼠认知功能的改善。
Sci Rep. 2025 Apr 24;15(1):14272. doi: 10.1038/s41598-025-97830-6.
10
Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo.可溶性重组tau聚集体对体内突触可塑性的不同破坏作用。
Mol Brain. 2025 Apr 18;18(1):36. doi: 10.1186/s13041-025-01208-8.
整合 TSPO PET 成像和转录组学以揭示神经炎症和淀粉样β沉积在阿尔茨海默病中的作用。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):455-467. doi: 10.1007/s00259-023-06446-3. Epub 2023 Oct 6.
4
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).早发性 AD 的淀粉样蛋白和 tau-PET:来自纵向早发性阿尔茨海默病研究(LEADS)的基线数据。
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S98-S114. doi: 10.1002/alz.13453. Epub 2023 Sep 10.
5
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.星形胶质细胞生物标志物 GFAP 和 YKL-40 介导早发性阿尔茨海默病的进展。
Alzheimers Dement. 2024 Jan;20(1):483-493. doi: 10.1002/alz.13450. Epub 2023 Sep 10.
6
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases.转位蛋白是啮齿动物模型中活化小胶质细胞的标志物,但不是人类神经退行性疾病的标志物。
Nat Commun. 2023 Aug 28;14(1):5247. doi: 10.1038/s41467-023-40937-z.
7
The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment.阿尔茨海默病中的线粒体蛋白 TSPO:与 AD 病理严重程度和神经炎症环境的关系。
J Neuroinflammation. 2023 Aug 14;20(1):186. doi: 10.1186/s12974-023-02869-9.
8
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies.原发性和转发性 tau 病患者中 Aβ-、tau-和神经退行性变(ATN)与小胶质细胞激活的个体区域关联。
Mol Psychiatry. 2023 Oct;28(10):4438-4450. doi: 10.1038/s41380-023-02188-8. Epub 2023 Jul 26.
9
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.使用 Tau PET 根据 Braak 分期框架分期阿尔茨海默病。
J Nucl Med. 2023 Aug;64(8):1171-1178. doi: 10.2967/jnumed.122.265200. Epub 2023 Jun 15.
10
ε4 associates with microglial activation independently of Aβ plaques and tau tangles.ε4 与小胶质细胞激活有关,与 Aβ 斑块和 tau 缠结无关。
Sci Adv. 2023 Apr 5;9(14):eade1474. doi: 10.1126/sciadv.ade1474.